Melius Pharma
1 known investors
Melius Pharma is a Swedish clinical-stage pharmaceutical company developing treatments for severe diseases with high unmet clinical need by sourcing assets with lower development risk. Its lead candidate, ME-015 (Suplatast tosilate), is an oral therapy for chronic cough in idiopathic pulmonary fibrosis (IPF) patients.
BiotechHealthtech
Investors · 1
Frequently asked questions
- What does Melius Pharma do?
- Melius Pharma is a Swedish clinical-stage pharmaceutical company developing treatments for severe diseases with high unmet clinical need by sourcing assets with lower development risk. Its lead candidate, ME-015 (Suplatast tosilate), is an oral therapy for chronic cough in idiopathic pulmonary fibrosis (IPF) patients.
- Who are Melius Pharma's investors?
- Melius Pharma's investors include FSG.